PROphylaxis for paTiEnts at Risk of COVID-19 infecTion
Status:
Withdrawn
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
The PROTECT open-label randomised basket trial will assess the effectiveness of
hydroxychloroquine (HCQ) as chemoprophylaxis against COVID-19 in multiple vulnerable
populations in the United Kingdom.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Cambridge University Hospitals NHS Foundation Trust